BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

923 related articles for article (PubMed ID: 33462723)

  • 1. Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.
    Anton-Vazquez V; Clivillé R
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1353-1355. PubMed ID: 33462723
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.
    Watanabe JH; Kwon J; Nan B; Abeles SR; Jia S; Mehta SR
    JAMA Netw Open; 2021 May; 4(5):e2110775. PubMed ID: 34019090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
    Desai A; Santonocito OG; Caltagirone G; Kogan M; Ghetti F; Donadoni I; Porro F; Savevski V; Poretti D; Ciccarelli M; Martinelli Boneschi F; Voza A
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33138045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.
    Mehta HB; An H; Andersen KM; Mansour O; Madhira V; Rashidi ES; Bates B; Setoguchi S; Joseph C; Kocis PT; Moffitt R; Bennett TD; Chute CG; Garibaldi BT; Alexander GC;
    Ann Intern Med; 2021 Oct; 174(10):1395-1403. PubMed ID: 34399060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns in US patients hospitalized with COVID-19 and pulmonary involvement.
    Best JH; Kong AM; Kaplan-Lewis E; Brawley OW; Baden R; Zazzali JL; Miller KS; Loveless J; Jariwala-Parikh K; Mohan SV
    J Med Virol; 2021 Sep; 93(9):5367-5375. PubMed ID: 33913536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Covid-19.
    Berlin DA; Gulick RM; Martinez FJ
    N Engl J Med; 2020 Dec; 383(25):2451-2460. PubMed ID: 32412710
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible treatment and strategies for COVID-19: review and assessment.
    Trivedi N; Verma A; Kumar D
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
    Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
    J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The medicinal treatment of COVID-19: a brief update].
    de Boer MGJ; Gieling EM; van der Linden PD; Sinha BNM; Vollaard AM
    Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33331727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The race against COVID-19.
    Nat Nanotechnol; 2020 Apr; 15(4):239-240. PubMed ID: 32303704
    [No Abstract]   [Full Text] [Related]  

  • 11. Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.
    Gressens SB; Esnault V; De Castro N; Sellier P; Sene D; Chantelot L; Hervier B; Delaugerre C; Chevret S; Molina JM;
    PLoS One; 2022; 17(2):e0262564. PubMed ID: 35176057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A metaresearch study revealed susceptibility of Covid-19 treatment research to white hat bias: first, do no harm.
    Bellos I
    J Clin Epidemiol; 2021 Aug; 136():55-63. PubMed ID: 33775812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
    Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
    FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing antimalarials and other drugs for COVID-19.
    Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
    Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-world treatment patterns and clinical outcomes for inpatients with COVID-19 in the US from September 2020 to February 2021.
    Ayodele O; Ren K; Zhao J; Signorovitch J; Jonsson Funk M; Zhu J; Bao Y; Gondek K; Keenan H;
    PLoS One; 2021; 16(12):e0261707. PubMed ID: 34962924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the effect of drugs on ACE2 as a novel target site for COVID-19 therapy.
    Hetta HF; Muhammad K; Algammal AM; Ramadan H; Abdel-Rahman MS; Mabrok M; Koneru G; Elkady AA; El-Saber Batiha G; Waheed Y; Munawar N; Farghaly HSM
    Eur Rev Med Pharmacol Sci; 2021 May; 25(10):3923-3932. PubMed ID: 34109607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.
    Colson P; La Scola B; Lagier JC; Gautret P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106238. PubMed ID: 33408030
    [No Abstract]   [Full Text] [Related]  

  • 18. Research shows racial disparity, mortality data for patients with cancer and COVID-19.
    Printz C
    Cancer; 2021 Feb; 127(3):333. PubMed ID: 33434336
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels.
    Szendrey M; Guo J; Li W; Yang T; Zhang S
    J Pharmacol Exp Ther; 2021 May; 377(2):265-272. PubMed ID: 33674391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Remdesivir in Myasthenia gravis and COVID-19.
    Peters BJ; Rabinstein AA; DuBrock HM
    Pharmacotherapy; 2021 Jun; 41(6):546-550. PubMed ID: 33835512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.